Par Pharma Sued For Abusing Monopoly Of Vasopressin
Fresenius Kabi USA LLC on Wednesday filed suit in a New Jersey federal court against Par Pharmaceutical Cos. Inc., the maker of an intravenous vasopressin solution, alleging the company abused its...To view the full article, register now.
Already a subscriber? Click here to view full article